Mangoceuticals (MGRX) Inventory Average (2023 - 2024)
Mangoceuticals recorded quarterly Inventory Average of -$2644.0 in Q4 2024, down 119.42% quarter-over-quarter from $13616.0 in Q3 2024, and down 113.19% year-over-year from $20041.0 in Q1 2024.
Mangoceuticals' Inventory Average history runs 2 years deep, the most recent figure standing at -$2644.0 for Q4 2024.
- In Q4 2024, Inventory Average fell 113.19% year-over-year to -$2644.0; the TTM figure through Dec 2024 stood at -$2644.0 (down 113.19% YoY), while the FY2024 annual figure was $0.0, changed N/A from the prior year.
- Inventory Average came in at -$2644.0 for Q4 2024 at Mangoceuticals, down from $13616.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $22537.5 in Q3 2023 to a low of -$2644.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 687.67 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 14.90 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 54.91 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 100.05 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,644.00 |
| Sep 30, 2024 | 13,616.00 |
| Jun 30, 2024 | 14,235.50 |
| Mar 31, 2024 | 16,476.50 |
| Dec 31, 2023 | 20,041.00 |
| Sep 30, 2023 | 22,537.50 |